NCT03047616View on ClinicalTrials.gov

A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

November 22, 2016

Primary Completion Date

January 1, 2019

Study Completion Date

May 31, 2019

Conditions
Lung Cancer
Interventions
OTHER

Blood and Urine Collection

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT03047616 - A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer | Biotech Hunter | Biotech Hunter